Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0PK5M
|
||||
| Former ID |
DNCL003778
|
||||
| Drug Name |
MLN0002
|
||||
| Synonyms |
Vedolizumab
|
||||
| Company |
Takeda
|
||||
| CAS Number |
CAS 943609-66-3
|
||||
| Target and Pathway | |||||
| Target(s) | Integrin alpha-4/beta-7 | Target Info | Modulator | [533123] | |
| References | |||||
| Ref 533123 | 2014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81. | ||||
| Ref 542460 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7437). | ||||
| Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.